News Releases

Webcast

AtriCure at the 39th Annual J.P. Morgan Healthcare Conference

01/11/21 7:30 AM EST

Webcast Presentation

Webcast

AtriCure at Piper Sandler 32nd Annual Virtual Healthcare Conference

12/01 - 12/03/20

Webcast Presentation

Webcast

AtriCure at Stifel Healthcare Conference

11/18/20 11:20 AM EST

Webcast Presentation

Webcast

Q3 2020 AtriCure, Inc. Earnings Conference Call

11/05/20 4:30 PM EST

Webcast Presentation

Date	Title
01/11/21	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020 Fourth quarter 2020 worldwide revenue of $57.7 million ( U.S. $47.4 million , International $10.3 million ) MASON, Ohio --(BUSINESS WIRE)--Jan. 11, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management,
01/04/21	AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy Expansion includes adolescent patients, as young as 12 years of age, who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall. MASON, Ohio --(BUSINESS WIRE)--Jan. 4, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial

Search form